Zobrazeno 1 - 10
of 19
pro vyhledávání: '"S. A. Pushkareva"'
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 76-80 (2022)
This article reviews the role of recombinant erythropoietin in the management of anemia in cancer patients based on literature data and our experience. We describe the problem of toxicity and report clinical recommendations and cautions for usage of
Externí odkaz:
https://doaj.org/article/9892bdef0d484eeda9c2f49abb0f7675
Autor:
N. V. Leonova, S. V. Pushkareva
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 4, Pp 30-34 (2016)
All recently known scores are applicable for long-term cardiovascular prognosis (CVP) for ≥10 years, and do underestimate the risk cardiovascular diseases (CVD) in persons with second type diabetes (DM). For the real clinical practice there is dema
Externí odkaz:
https://doaj.org/article/59fbe772733943aa80c2fef53f89452c
Autor:
N. A. Kraskovskaya, A. I. Erofeev, E. D. Grishina, S. A. Pushkareva, E. I. Gerasimov, O. L. Vlasova, I. B. Bezprozvanny
Publikováno v:
Journal of Evolutionary Biochemistry and Physiology. 57:1449-1460
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 4, Pp 55-58 (2015)
Metabolic syndrome (MS) is almost always associated with diabetes of 2nd type. However recent data puts that MS might develop in patients with 1st type diabetes (DM1), and insulin resistance as its base may lead to worsening of macro- and microvascul
Externí odkaz:
https://doaj.org/article/0513cdc7ffdb4a88aa70d7b007ca38ed
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 3, Pp 102-106 (2014)
Patients with Type 1 diabetes mellitus (DM-1) represent a heterogeneous group with different phenotypes, which might include some individuals with genetic predisposition towards insulin resistance (IR) and metabolic phenotype (MPH) development. At pr
Externí odkaz:
https://doaj.org/article/5c58d041812745849ae633e8658d59a8
Autor:
Xiangyu Yang, Haoyu Yang, D. S. Barinov, A. I. Erofeev, M. V. Bolsunovskaja, Evgenii Gerasimov, Chengbin Zhou, Ilya Bezprozvanny, O. L. Vlasova, Wcidong Li, S. A. Pushkareva
Publikováno v:
Журнал высшей нервной деятельности им И П Павлова. 70:852-864
Publikováno v:
КардиоСоматика, Vol 6, Iss 1-1 (2015)
Цель. Изучить взаимосвязь кардиометаболических факторов риска (ФР) с макроангиопатиями у пациентов с сахарным диабетом 2-го типа (СД 2).Ма
Externí odkaz:
https://doaj.org/article/5159a2cc0a6b486f94a7d6d842b0acb4
Autor:
E I Gerasimov, A I Erofeev, S A Pushkareva, A V Bol’shakova, A A Borodinova, P M Balaban, I B Bezprozvanny, O L Vlasova
Publikováno v:
Journal of Physics: Conference Series. 2086:012110
The method of optogenetics has spread widely in neurobiology over the past 10 years and has found extensive application in various fields of this sciences. It allows to control and regulate cellular activity with high spatial and temporal resolution.
Autor:
G D, Selidovkin, S G, Pushkareva, E E, Obukhova, K N, Melkova, Gorbunova, S V, Vorob'eva, A A, Davtian, N B, Danilova, Konchalovskiĭ, A E, Baranov
Publikováno v:
Gematologiia i transfuziologiia. 41(1)
The success in acute myeloblastic leukemia (AML) treatment for the last 10 years has been referred to growing intensity of chemotherapy. The efficacy of treatment has been assessed in 56 patients under 60 years of age. Double induction of remission a
Autor:
A E, Baranov, N M, Nadezhina, L N, Petrosian, S G, Pushkareva, L V, Evseeva, T V, Shishkova, T A, Nasonova, V N, Mal'tsev, T A, Vasina, L D, Feoktistova
Publikováno v:
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 36(10)
Clinical efficacy of intravenous gentamicin in combination with oral use of gentamicin, ristomycin and nystatin was studied in 1977. In 1980-1984 two antiinfectious regimens were tested: intravenous administration of gentamicin in combination with to